Summit Therapeutics (MEX:SMMT) Shares Buyback Ratio % : -5.13 (As of Mar. 30, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Summit Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Summit Therapeutics's current shares buyback ratio was -5.13%.

Summit Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Summit Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Summit Therapeutics Shares Buyback Ratio % Chart

Summit Therapeutics Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-157.42

-18.73

-115.31

-232.40

-5.13

Summit Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.55	-0.04	-3.18	-1.76	-0.07

Summit Therapeutics Shares Buyback Ratio % Calculation

Summit Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(701.660	-	737.626)	/	701.660
	=	-5.13%

Summit Therapeutics's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	(737.095	-	737.626)	/	737.095
	=	-0.07%

Summit Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Summit Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Summit Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics Inc (MEX:SMMT) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

SMMT:USA

Address

601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131

Website

https://www.smmttx.com

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.